QNTM
QUANTUM BIO-SB (QNTM)
NASDAQ
$4.97+$0.09 (+1.93%)
Price as of Jun 03, 2026 7:51 PM EDT
  • $43.9M
    Market Cap
  • -66.41%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
9.0M
+1,368.81%
616,002
0.00%
616,002
0.00%
616,002
N/A
Research and Development Expense
-2.8M
-54.58%
-6.1M
+57.63%
-3.9M
-44.16%
-6.9M
+9.21%
Depreciation and Amortization Expense
545,780
+11.25%
490,571
-80.43%
2.5M
-44.73%
4.5M
+12.09%
Total Operating Expenses
9.0M
-3.85%
9.4M
+4.18%
9.0M
-37.49%
14.5M
-9.27%
Operating Profit
-15.3M
N/A
N/A
N/A
N/A
N/A
-27.4M
-18.71%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-9,343
-61.53%
-24,288
-83.80%
-149,906
N/A
Interest Income and Expense and Net
0
+100.00%
-9,343
-61.53%
-24,288
-83.80%
-149,906
N/A
Total Nonoperating Income and Expense
1.9M
+48,696.47%
3,989
-83.58%
24,288
-83.80%
149,906
+11,502.63%
Income before Taxes
-27.2M
+75.74%
-15.5M
-15.00%
-18.2M
-22.88%
-23.6M
-33.10%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-27.2M
+75.74%
-15.5M
-15.00%
-18.2M
-22.88%
-23.6M
-33.10%
Net Income from Continuing Operations Applicable to Common
-27.2M
+75.74%
-15.5M
-15.00%
-18.2M
-22.88%
-23.6M
-33.10%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-8.20
N/A
N/A
N/A
N/A
N/A
-0.69
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
38.7M
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
38.7M
N/A
Balance Sheet
Cash and Cash Equivalents
1.9M
-68.22%
6.0M
+117.47%
2.8M
-83.76%
17.0M
-51.84%
Short-Term Investments
459,080
-61.82%
1.2M
+59.02%
756,100
N/A
0
-100.00%
Cash and Cash Equivalents and Short-Term Investments
2.4M
-67.15%
7.2M
+104.89%
3.5M
-79.31%
17.0M
-52.06%
Total Current Assets
6.5M
-46.25%
12.1M
+8.73%
11.1M
-37.90%
17.9M
-61.14%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
67,029
-12.83%
76,894
-12.20%
87,583
-17.16%
105,729
-98.78%
Total Long-Term Assets
4.7M
-7.58%
5.1M
-7.58%
5.5M
-58.24%
13.1M
N/A
Total Assets
11.2M
-34.80%
17.1M
-2.03%
17.5M
-54.51%
38.4M
-38.99%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.1M
-9.29%
6.7M
+46.29%
4.6M
-41.69%
7.8M
-10.01%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
492,002
+1,469.99%
31,338
N/A
N/A
N/A
Total Liabilities
6.1M
-9.29%
6.7M
+46.29%
4.6M
-41.98%
7.9M
-10.91%
Retained Earnings
-198.3M
+15.21%
-172.1M
+8.99%
-157.9M
+9.53%
-144.2M
+14.28%
Total Stockholders Equity
5.1M
-51.13%
10.4M
-19.13%
12.9M
-57.73%
30.5M
-43.58%
Total Shares Outstanding
42
-99.90%
42,456
-99.89%
39.4M
+2.27%
38.5M
-4.81%
Cash Flow
Cash from Operating Activities
-8.2M
+19.79%
-6.9M
-36.49%
-10.8M
-61.79%
-28.3M
+36.57%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-2.0M
+29.86%
-1.5M
+457.74%
-269,579
-102.22%
12.1M
+4,407.45%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.1M
-47.51%
11.6M
+471.61%
-3.1M
+51.09%
-2.1M
-105.42%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-192.31%
+114.98%
-89.46%
+37.31%
-65.15%
+39.89%
-46.57%
-30.75%
Return on Equity
-349.92%
+164.01%
-132.54%
+58.17%
-83.79%
+50.28%
-55.76%
-28.54%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.07
-40.75%
1.80
-25.68%
2.43
+6.51%
2.28
-56.82%
Cash Ratio
0.31
-64.97%
0.90
+48.65%
0.60
-72.15%
2.17
-46.49%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow